Topics

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

The new platform offers coupon-driven discounts on dozens of high-cost brand name drugs, while raising new questions about eligibility, access, and how savings are applied.

TrumpRx Launches With MFN-Based Drug Discounts 

Podcasts

In today’s Pharma Pulse, the FTC secures a multi-billion-dollar settlement against the "rebate trap," while Congress provides long-term certainty for the digital health revolution.

Pharma Pulse: PBM Reform Hits the Courtroom and Telehealth’s Legislative Victory

A landmark FTC settlement requires Express Scripts to overhaul formulary and rebate practices, boosting price transparency in the process. 

FTC–Express Scripts Settlement Targets PBM Rebates, Transparency, and Patient Drug Costs

In today’s Pharma Pulse, the biopharma landscape enters a transformative phase as the US signs landmark PBM reforms into law, while Novartis braces for the largest patent expiration cycle in its history.

Pharma Pulse: Transparency Mandates and the Novartis Patent Storm

The acquisition expands ORBIS’ manufacturing capacity and technical expertise in reusable plastic pallets, lids, and trays, enabling faster design, prototyping, and production for pharma and broader supply chain applications.

ORBIS Acquires Robinson Industries to Boost Reusable Packaging and Thermoforming Capabilities

The deal strengthens Körber’s SAP supply chain and digital manufacturing consulting portfolio, extends its global footprint, and creates Körber Stellium to deliver end-to-end supply chain and software solutions.

Körber Purchases Majority Stake in Stellium to Grow Global SAP Supply Chain Consulting Services

In today’s Pharma Pulse, a new national survey exposes the depth of America’s prescription access crisis, while AstraZeneca and Eli Lilly commit billions of dollars to next-generation weight-loss therapies and domestic manufacturing.

Pharma Pulse: The Access Gap

In today’s Pharma Pulse, HHS issues guidance for manufacturer-direct drug discounts, while clinical data warns of significant weight regain after stopping tirzepatide and semaglutide.

Pharma Pulse: HHS Bypasses PBMs and the Reality of GLP-1 Weight Regain

For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, naming 15 new negotiation targets and signaling continued efforts to rein in prescription drug spending.

CMS Announces Selection of Drugs for Third Cycle of Medicare Drug Price Negotiation Program, Including First-Ever Part B Drugs

In today’s Pharma Pulse, the AAP defies federal vaccine cuts, Morris & Dickson scales its specialty footprint, and Insilico Medicine targets cardiometabolic health with a new partnership.

Business and Finance